Biovac A Vaccine is indicated for active vaccination against infection caused by human hepatitis A virus (HAV) in persons over one and a half years of age. Biovac A Vaccine may be used for the primary course of immunisation. Biovac A Vaccine is recommended for pre-exposure prophylaxis and post-exposure prophylaxis in persons at increased risk.
Biovac A Vaccine is a freeze-dried, live attenuated hepatitis A vaccine that is administered by injection. It's usually given in two doses, with the second dose given six to 12 months after the first. This type of Biovac A Vaccine is effective in the prevention of hepatitis A infection and is considered safe for use in people 1 year of age and older.
Biovac A Vaccine only protects against hepatitis A. There is a separate vaccine for hepatitis B. There is also a combination of hepatitis A and hepatitis B vaccines that provide protection against both viruses. There is currently no vaccine for hepatitis C.
Biovac A Vaccine should not be given to anyone with a known hypersensitivity to any of its components. In addition, it is recommended that Biovac A Vaccine should not be administered during a high fever.
Biovac A Vaccine may cause some common side effects including nausea, pain, abdominal pain, anaphylactic reaction, convulsions, fatigue and headache, loss of appetite, tenderness and vomiting. It is recommended that you seek medical advice if these symptoms persist or cause discomfort. Your doctor will be able to advise you on how to manage any side effects.
Before taking Biovac A Vaccine, tell your doctor or nurse if you have any pre-existing medical conditions such as kidney or liver disease, fever or other illnesses, or if you are currently taking any medicines, herbs, vitamins, etc. Also, tell them if you are pregnant or breastfeeding.
Prevention of hepatitis A infection: Biovac A Vaccine is used to protect against liver infection caused by the hepatitis A virus. It is mainly spread by contact with an infected person or by eating contaminated food or water. Symptoms include tiredness, nausea, stomach pain and jaundice (yellowing of the skin and eyes). If you're taking Biovac A, you'll need to take extra precautions to avoid getting infected, but practising good hygiene, such as washing your hands frequently, especially before eating or preparing food, can also help reduce your risk. Avoiding close contact with those who carry the virus and practising safer sex can also help to reduce your risk.
The Biovac A Vaccine is used to prevent hepatitis A, an infection that can cause the liver to become inflamed. It works by stimulating the immune system to produce antibodies to fight the virus. The Biovac A Vaccine is usually recommended for people who are more likely to get hepatitis A and is administered by injecting into a muscle. For the best protection, it is recommended that the vaccine is administered at least two weeks before possible exposure to the virus.
The Biovac A Vaccine is given by injecting into a muscle. It is usually recommended that the Biovac A Vaccine is given in two doses, with the second dose being given 6 to 12 months after the first dose. When administering Biovac A Vaccine, it is important to follow the instructions given by your doctor or on the package leaflet.
The Biovac A Vaccine works by introducing a small, harmless part of the hep A virus into the body. This triggers the immune system to produce antibodies against the virus, which remain in the body and help protect against future hepatitis A infections. The Biovac A Vaccine does not contain live virus and therefore cannot be the cause of the disease. If a person who has been vaccinated is exposed to the virus, his or her immune system will recognise it and produce the necessary antibodies to fight it off, thus preventing the person from becoming ill.
Drinking alcohol while taking Biovac A Vaccine is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
There are no data on the presence of Biovac A Vaccine or its metabolites in human milk or effects on nursing infants or lactation. Because of the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Biovac A Vaccine and for 2 weeks after the last dose.
It is uncertain if the Biovac A Vaccine affects one's ability to drive. If any symptoms that impair focus and reaction occur, do not operate a vehicle.
The use of Biovac A Vaccine is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
Biovac A Vaccine should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Biovac A Vaccine and report any unusual symptoms or changes in kidney function to their doctor. The dose of Biovac A Vaccine may need to be adjusted in patients with kidney disease.
Biovac A Vaccine should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Biovac A Vaccine and report any unusual symptoms or changes in liver function to their doctor. The dose of Biovac A Vaccine may need to be adjusted in patients with liver disease.
1, Immunogenicity And Safety Of Live Attenuated Hepatitis A Vaccine (biovac-a) In Healthy Indian Children, Dovepress, available Form
2. Long-term Immunogenicity Of Single Dose Of Live Attenuated Hepatitis A Vaccine In Indian Children, Sheila Bhave, Amita Sapru, Ashish Bavdekar, Vaibhav Kapatkar And Amey Mane. From Department Of Pediatrics, Kem Hospital Research Centre, Pune; And department Of Medical Affairs, Wockhardt Limited, Mumbai; India. Available Form
3. Havrix 1440 (adult) / 720 (junior), Inactivated Hepatitis A Vaccine (adsorbed) Ip, GlaxoSmithKline Pharmaceuticals Limited, India, Product Leaflet
4. Havrix Junior Monodose Vaccine, Hepatitis A Vaccine (inactivated, Adsorbed). 720 Elisa Units/ 0.5 Ml. Suspension For Injection In A Pre-filled Syringe, Gsk, Available Form